PASG
Passage Bio·NASDAQ
--
--(--)
--
--(--)
PASG fundamentals
Passage Bio (PASG) released its earnings on Nov 10, 2025: revenue was 0 (YoY --), met estimates; EPS was -2.44 (YoY +60.65%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-2.44
+60.65%
Report date
Nov 10, 2025
EPS
Actual | -20 | -12 | -12.6 | -17 | -15.2 | -18 | -17.4 | -19 | -15.8 | -14.6 | -9.8 | -10 | -12.6 | -8.8 | -9.8 | -6 | -6 | -5.2 | -6.2 | -4 | -5 | -2.96 | -2.44 |
Forecast | -8.7153 | -11.1 | -14.75 | -13.7682 | -14.6526 | -14.6858 | -16.8566 | -17.4391 | -17.7527 | -16.6212 | -15.5445 | -10.459 | -10.7813 | -9.4667 | -9.1333 | -7.72 | -7.15 | -6.1848 | -4.6357 | -4.3 | -4.6 | -4.04 | -2.7575 |
Surprise | -129.48% | -8.11% | +14.58% | -23.47% | -3.74% | -22.57% | -3.22% | -8.95% | +11.00% | +12.16% | +36.96% | +4.39% | -16.87% | +7.04% | -7.30% | +22.28% | +16.08% | +15.92% | -33.74% | +6.98% | -8.70% | +26.73% | +11.51% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.67M | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What does Passage Bio do and what are its main business segments?What factors drove the changes in Passage Bio's revenue and profit?What is the market's earnings forecast for Passage Bio next quarter?What were the key takeaways from Passage Bio’s earnings call?What were the key takeaways from Passage Bio's earnings call?What is Passage Bio's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Passage Bio year over year?What guidance did Passage Bio's management provide for the next earnings period?
